Anti-tumor agent assay using PKR
    1.
    发明授权
    Anti-tumor agent assay using PKR 失效
    使用PKR的抗肿瘤剂测定

    公开(公告)号:US5670330A

    公开(公告)日:1997-09-23

    申请号:US143219

    申请日:1993-10-25

    IPC分类号: G01N33/50 G01N33/573 C12Q1/48

    CPC分类号: G01N33/573 G01N33/5011

    摘要: A method of screening human tissue for the presence of neoplastic cells, by determining the activity of PKR, P58 of anti-P58 in test cells being screened, and identifying candidate neoplastic cells on the basis of subnormal PKR, P58, or anti-P58 activity. The activities may be determined directly by measuring protein kinase activity or its equivalent, or measured indirectly, by detecting functional mutations in the various proteins. Also disclosed are assay kits for carrying out the screening method.

    摘要翻译: 通过在被筛选的测试细胞中测定抗P58的PKR活性,P58的活性,以及​​基于正常PKR,P58或抗P58活性的候选肿瘤细胞鉴定候选肿瘤细胞,筛选人组织存在肿瘤细胞的方法 。 活性可以通过测定蛋白激酶活性或其等同物直接测定,或通过检测各种蛋白质中的功能性突变间接测定。 还公开了用于进行筛选方法的测定试剂盒。